Rafael Silvestrin

Rafael Silvestrin serves as Gerente de Desenvolvimento Analítico at Instituto Butantan since January 2022. Responsibilities include overseeing a team focused on analytical development, validation, and internalization of methods in line with regulatory standards, specifically for advanced therapies such as Fator VII and CAR-T cells. Prior roles encompass leadership positions at Aché Laboratórios Farmacêuticos, Quality Compliance, Apsen Farmacêutica, União Química Farmacêutica Nacional, Medley, Eurofarma, and Sandoz do Brasil, demonstrating extensive experience in analytical research and development, method validation, and quality management. Educational background includes an MBA in Business Management from USP/Esalq and a degree in Industrial Chemistry from UNOPAR, complemented by ongoing specialization in Business Intelligence & Analytics.